NCT01827878View on ClinicalTrials.gov

Bioequivalence Study of Lisinopril and Hydrochlorothiazide Tablets (20+25) mg Under Fed Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
Fed
Interventions
DRUG

Lisinopril and Hydrochlorothiazide Tablets (20+25) mg

Lisinopril and Hydrochlorothiazide (20+25) mg Tablets once a day

DRUG

Zestoretic® 20/25 lisinopril/hydrochlorothiazide Tablets

Zestoretic® 20/25 lisinopril/hydrochlorothiazide Tablets once a day

Trial Locations (1)

380059

Accutest Research Lab (I) Pvt. Ltd., Ahmedabad

Sponsors
All Listed Sponsors
lead

IPCA Laboratories Ltd.

INDUSTRY